CClinicalTrials.gg
Status unknownNCT02740751GalactogogueUpdated Apr 18, 2016

Efficacy of Herbal Galactogogues in Breastfeeding Mothers

An interventional study of Still-Tee in Weight Gain, sponsored by Dr. Sami Ulus Children's Hospital. Status unknown at 1 site in Turkey. Open to participants aged 3 Days to 30 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-18.

Sponsored by Dr. Sami Ulus Children's Hospital · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Apr 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
3 Days to 30 Days
Sex
All
01

Study summary

Herbal teas with galactogoge effects have been used extensively in recent years in order to increase the amount of breast milk in lactating mothers. We also investigated whether a sleep-induced herbal tea (Still-Tee; Mamsel®) was effective in regulating the sleep of these mothers. Plain water was used as placebo.

Read the detailed description

Herbal teas with galactogoge effects have been used extensively in recent years in order to increase the amount of breast milk in lactating mothers. Mothers of premature babies often have problems in breastfeeding and this study was designed to investigate if such herbal teas has any effect on the increasing of breast milk in mothers of premature babies. We also investigated whether a sleep-induced herbal tea (Still-Tee; Mamsel®) was effective in regulating the sleep of these mothers. Plain water was used as placebo.

02

Conditions studied

  • Weight Gain

Browse trials for

03

In context

Weight Gain

405 studies on the registry are indexed under Weight Gain; 53 are open to participants now.

This study's planned enrollment of 90 is close to the median of 83 across 324 interventional studies indexed under Weight Gain.

Browse Weight Gain studies →

Lead sponsor

Dr. Sami Ulus Children's Hospital is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Days to 30 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Babies with gestational age of 35-42 weeks
  • Breasfed babies
  • Lactating mothers
  • Babies admitted to outpatient clinics of neonatology within the the first week of life

Exclusion criteria

Exclusion Criteria:

  • Babies with gestational age of \<35 weeks
  • Not breast feeding mothers
  • Babies admitted to outpatient clinics of neonatology within the the first week of life
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Still-Tee

    Generic name: galactogoe herbal tee, still-tee Dosage: Three cups (each 200 ml) of tea of Still-Tee galactogogue tea will be used Frequency: Three times in a day Duration: for 4 weeks after birth

    Dietary Supplement: Still-Tee

  • Placebo comparator
    Placebo

    The mothers of the babies will receive placebo tea which does not contain galactogogue herbs

    Dietary Supplement: Still-Tee

  • No intervention
    Water

    The mothers of the babies will receive water

Interventions

  • Dietary supplementStill-Tee

    The mothers of the babies will receive Still-Tee galactogogue tea

06

What researchers measure

Primary outcomes

  1. Weight gain

    Time frame: 4 weeks

Secondary outcomes

  1. Breast milk volume

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Dr Sami Ulus Children Hospital
    Ankara, 06120, Turkey
    • Dilek Dilli, Assoc prof · Contact · dilekdilli2@yahoo.com · 00903123056000
    • Selcan Yılmaz, MD · Sub investigator
    Recruiting
08

References and documents

Publications

  • Foong SC, Tan ML, Foong WC, Marasco LA, Ho JJ, Ong JH. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev. 2020 May 18;5(5):CD011505. doi: 10.1002/14651858.CD011505.pub2. PubMed 32421208 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02740751
Lead sponsor
Dr. Sami Ulus Children's Hospital
Responsible party
Dilek Dilli (MD, Assoc Prof, Dr. Sami Ulus Children's Hospital) — Principal investigator
First posted
Apr 15, 2016
Start date
Apr 2016
Primary completion
Jan 2017 (estimated)
Completion
Apr 2017 (estimated)
Last update
Apr 18, 2016

Study contacts

Dilek Dilli, Assoc Prof
Contact
dilekdilli2@yahoo.com
0903056310 ext. 6310
Dilek Dilli, Assoc Prof
study director · Dr Sami Ulus Research and Training Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion